With federal public health agencies under the helm of Robert F. Kennedy Jr., a longtime vaccine critic, the usual schedule ...

Biotechnology company Moderna (NASDAQ:MRNA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 41.1% year ...

Moderna (MRNA) skyrocketed to fame during the pandemic, delivering one of the first mRNA-based Covid-19 vaccines and quickly ...

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...

Pulling the Pfizer EUA would remove the only COVID-19 vaccine approved for all children from the US market. The Moderna ...

Kennedy’s $500M cut to mRNA funding puts startups at risk and imperils one of life sciences’ few leasing bright spots.

U.S. Sen. Bill Cassidy is admonishing Health Secretary Robert F. Kennedy's decision to cancel about $500 million in vaccine ...

Infectious disease experts say the mRNA technology used in vaccines is safe, and they credit its development during the first Trump administration with slowing the 2020 coronavirus pandemic.

The Trump Administration said this week it is pulling half a billion dollars from U.S. government-funded research projects to ...

RNA expert Jeff Coller spoke with Live Science about the future of mRNA vaccines in the United States in the aftermath of ...

The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...